Cargando…

Immunogenicity of RSV F DNA Vaccine in BALB/c Mice

Respiratory syncytial virus (RSV) causes severe acute lower respiratory tract disease leading to numerous hospitalizations and deaths among the infant and elderly populations worldwide. There is no vaccine or a less effective drug available against RSV infections. Natural RSV infection stimulates th...

Descripción completa

Detalles Bibliográficos
Autores principales:	Eroglu, Erdal, Singh, Ankur, Bawage, Swapnil, Tiwari, Pooja M., Vig, Komal, Pillai, Shreekumar R., Dennis, Vida A., Singh, Shree R.
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Hindawi Publishing Corporation 2016
Materias:	Research Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5027326/ https://www.ncbi.nlm.nih.gov/pubmed/27688769 http://dx.doi.org/10.1155/2016/7971847

Ejemplares similares

Antibiotic Minocycline Prevents Respiratory Syncytial Virus Infection
por: Bawage, Swapnil S., et al.
Publicado: (2019)

Recent Advances in Diagnosis, Prevention, and Treatment of Human Respiratory Syncytial Virus
por: Bawage, Swapnil Subhash, et al.
Publicado: (2013)

Functionalized carbon nanotubes: biomedical applications
por: Vardharajula, Sandhya, et al.
Publicado: (2012)

A nonviral pHEMA+chitosan nanosphere-mediated high-efficiency gene delivery system
por: Eroglu, Erdal, et al.
Publicado: (2013)

Novel cationic peptide TP359 down-regulates the expression of outer membrane biogenesis genes in Pseudomonas aeruginosa: a potential TP359 anti-microbial mechanism
por: Dosunmu, Ejovwoke F., et al.
Publicado: (2016)

Advances in Skin Regeneration Using Tissue Engineering
por: Vig, Komal, et al.
Publicado: (2017)

Functionalized Gold Nanoparticles and Their Biomedical Applications
por: Tiwari, Pooja M., et al.
Publicado: (2011)

Future Prospects for Scaffolding Methods and Biomaterials in Skin Tissue Engineering: A Review
por: Chaudhari, Atul A., et al.
Publicado: (2016)

Immunological challenges associated with artificial skin grafts: available solutions and stem cells in future design of synthetic skin
por: Dixit, Saurabh, et al.
Publicado: (2017)

Silver-coated carbon nanotubes downregulate the expression of Pseudomonas aeruginosa virulence genes: a potential mechanism for their antimicrobial effect
por: Dosunmu, Ejovwoke, et al.
Publicado: (2015)

Evaluation of E. coli inhibition by plain and polymer-coated silver nanoparticles
por: Ashmore, D'Andrea, et al.
Publicado: (2018)

Facile and rapid detection of respiratory syncytial virus using metallic nanoparticles
por: Valdez, Jesus, et al.
Publicado: (2016)

Anti-RSV Peptide-Loaded Liposomes for the Inhibition of Respiratory Syncytial Virus †
por: Joshi, Sameer, et al.
Publicado: (2018)

An RSV Live-Attenuated Vaccine Candidate Lacking G Protein Mucin Domains Is Attenuated, Immunogenic, and Effective in Preventing RSV in BALB/c Mice
por: Roe, Molly K, et al.
Publicado: (2022)

The anti-microbial peptide TP359 attenuates inflammation in human lung cells infected with Pseudomonas aeruginosa via TLR5 and MAPK pathways
por: Dosunmu, Ejovwoke F., et al.
Publicado: (2017)

2321. Long-term immunogenicity of Ad26.RSV.preF/RSV preF protein vaccine against RSV in a phase 2b study by age and risk level
por: Comeaux, Christy A, et al.
Publicado: (2022)

A novel covalent approach to bio-conjugate silver coated single walled carbon nanotubes with antimicrobial peptide
por: Chaudhari, Atul A., et al.
Publicado: (2016)

Novel pegylated silver coated carbon nanotubes kill Salmonella but they are non-toxic to eukaryotic cells
por: Chaudhari, Atul A, et al.
Publicado: (2015)

Decrease in Formalin-Inactivated Respiratory Syncytial Virus (FI-RSV) Enhanced Disease with RSV G Glycoprotein Peptide Immunization in BALB/c Mice
por: Rey, Gertrud U., et al.
Publicado: (2013)

Proteomic analysis of antimicrobial effects of pegylated silver coated carbon nanotubes in Salmonella enterica serovar Typhimurium
por: Park, Seong B., et al.
Publicado: (2018)

Immunogenicity and safety of a respiratory syncytial virus fusion protein (RSV F) nanoparticle vaccine in older adults
por: Fries, Louis, et al.
Publicado: (2017)

Neuroligin 4X overexpression in human breast cancer is associated with poor relapse-free survival
por: Henderson, Henry J., et al.
Publicado: (2017)

Combination Therapy Using Monoclonal Antibodies against Respiratory Syncytial Virus (RSV) G Glycoprotein Protects from RSV Disease in BALB/c Mice
por: Caidi, Hayat, et al.
Publicado: (2012)

Safety and Immunogenicity of a Live Attenuated RSV Vaccine in Healthy RSV-Seronegative Children 5 to 24 Months of Age
por: Malkin, Elissa, et al.
Publicado: (2013)

ChAd155-RSV vaccine is immunogenic and efficacious against bovine RSV infection-induced disease in young calves
por: de Jong, Rineke, et al.
Publicado: (2022)

Immunogenicity of SARS inactivated vaccine in BALB/c mice
por: Xiong, Sheng, et al.
Publicado: (2004)

2755. Phase 1/2, First-in-Human Study of the Safety, Tolerability, and Immunogenicity of an RSV Prefusion F-Based Subunit Vaccine Candidate
por: Schmoele-Thoma, Beate, et al.
Publicado: (2019)

Two RSV Platforms for G, F, or G+F Proteins VLPs
por: Ha, Binh, et al.
Publicado: (2020)

The importance of RSV F protein conformation in VLPs in stimulation of neutralizing antibody titers in mice previously infected with RSV
por: Cullen, Lori M., et al.
Publicado: (2017)

Safety and immunogenicity of novel respiratory syncytial virus (RSV) vaccines based on the RSV viral proteins F, N and M2-1 encoded by simian adenovirus (PanAd3-RSV) and MVA (MVA-RSV); protocol for an open-label, dose-escalation, single-centre, phase 1 clinical trial in healthy adults
por: Green, C A, et al.
Publicado: (2015)

RSV A2-Based Prefusion F Vaccine Candidates Induce RSV A and RSV B Cross Binding and Neutralizing Antibodies and Provide Protection against RSV A and RSV B Challenge in Preclinical Models
por: Cox, Freek, et al.
Publicado: (2023)

Immunogenicity and protective efficacy of DNA vaccine against visceral leishmaniasis in BALB/c mice
por: Kaur, Sukhbir, et al.
Publicado: (2016)

Nanofiller-Enhanced Soft Non-Gelatin Alginate Capsules for Modified Drug Delivery
por: Joshi, Sameer, et al.
Publicado: (2021)

Influenza and respiratory syncytial virus (RSV) vaccines for infants: Safety, immunogenicity, and efficacy
por: Beeler, Judy A., et al.
Publicado: (2013)

Intramuscular Inoculation of AS02-Adjuvanted Respiratory Syncytial Virus (RSV) F Subunit Vaccine Shows Better Efficiency and Safety Than Subcutaneous Inoculation in BALB/c Mice
por: Bian, Lijun, et al.
Publicado: (2022)

Exacerbated lung inflammation following secondary RSV exposure is CD4+ T cell-dependent and is not mitigated in infant BALB/c mice born to PreF-vaccinated dams
por: Kosanovich, Jessica L., et al.
Publicado: (2023)

Safety and Immunogenicity of the Respiratory Syncytial Virus Vaccine RSV/ΔNS2/Δ1313/I1314L in RSV-Seronegative Children
por: Karron, Ruth A, et al.
Publicado: (2020)

Flavonoid Naringenin: A Potential Immunomodulator for Chlamydia trachomatis Inflammation
por: Yilma, Abebayehu N., et al.
Publicado: (2013)

Anti-inflammatory effects of silver-polyvinyl pyrrolidone (Ag-PVP) nanoparticles in mouse macrophages infected with live Chlamydia trachomatis
por: Yilma, Abebayehu N, et al.
Publicado: (2013)

Immunogenicity of the nanovaccine containing intimin recombinant protein in the BALB/c mice
por: Hosseini, Zahra Sadat, et al.
Publicado: (2018)

Cannot write session to /tmp/vufind_sessions/sess_u7nrugba57blo9cg5av6vnplot